ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,223, issued on Sept. 9, was assigned to TRex Bio Inc. (South San Francisco, Calif.).
"TNF-alpha variant fusion molecules" was invented by Robin Allene Aglietti (South San Francisco, Calif.), Susannah Dale Barbee (San Francisco), Peter Michael Bowers (La Jolla, Calif.) and Melanie Angelika Kleinschek (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to TNF-alpha variants and TNF-alpha variant fusion molecules and therapeutic uses of such thereof."
The patent was filed on Nov. 8, 2024, under Application No. 18/942,121.
*For further information, including images, charts and tables, please visit: http://patf...